Study: CBD has Longer Treatment Window for Newborn Brain Damage than Other Treatments

Photo Credit: The Joint Blog

Photo Credit: The Joint Blog

A study found in the journal CNS & Neurological disorders - Drug Targets, and published by NIH, has discovered cannabidiol (CBD) not only can treat newborn brain damage, but the cannabinoid is also effective when administered at a longer time from the occurrence of the dramatic event than other treatments. Researchers gave CBD to newborn mice with brain damage 15 minutes after brain damage onset, and then again 1, 3, 6, 12, 18, and 24 hours later. They found “CBD administered up to 18 h after HI [hypoxic-ischemic brain damage] reduced IHVL and neuropathological score by 60%, TUNEL+ count by 90% and astrocyte damage by 50%. In addition, CBD blunted the HI-induced increase in microglial population.” By he time it hit 24 hours, the effects of CBD were reduced. Authors concluded, “CBD shows a TTW of 18 h when administered to HI newborn mice, which represents a broader TTW than reported for other neuroprotective treatments including hypothermia.”

This information has been provided by the Joint Blog. You can also find the study on the National Institute of Health's website